Research in Burlington
Science Explorer records 1 research institutions in Burlington, United States. The highest-ranked on research quality in 2022–2025 are LabCorp (United States).
- Research institutions
- 1 1 of them ranked worldwide
- Research works
- 1.2k ▲ 84% vs 2013–17
- Top-10% rate, 2022–2025
- 11.7% record average 16.5%
A city carries no overall standing here. The composite score is built for institutions and countries, the units its floors and field normalisation were designed around. An empty rank on this page is a statement about the measure, not about the place.
Which research institutions are in Burlington?
| # | Institution | Works | Against the largest here | World rank |
|---|---|---|---|---|
| 1 | LabCorp (United States)Company | 1,197 | #6,768 |
By fractional works over the whole record; world rank on research quality in 2022–2025. Bars are scaled to the largest institution in this city, not to anything off the page.
What is Burlington strongest at in research?
Relative to its size, research in Burlington is most concentrated in Oncology (5.9× the world share in Oncology).
- OncologySubfield · 29.1 works5.9×
Location quotient against the world baseline. Inside a single field a city is a meaningful unit, which is why this is where a city is measured at all.
Which keywords describe research in Burlington?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Epidemiology, Targeted Therapy, Cell-Free DNA, Inflammation, Metabolic Syndrome, Genomic Instability and Tumor Microenvironment.
- Therapeutic Antibodies
- Antibody Engineering
- Prenatal Diagnosis
- Mass Spectrometry
- Gene Therapy
- Genetic Testing
- Prognostic Factors
- Data Analysis
- Immune Checkpoint Blockade
- Tumor Regression
- Monoclonal Antibodies
- Chemotherapy
- Biomarkers
- Cancer Genomics
- Oxidative Stress
- Clinical Trials
- Tumor Microenvironment
- Metabolic Syndrome
- Targeted Therapy
- Inflammation
- Epidemiology
- Immunotherapy
- Cell-Free DNA
- Machine Learning
- Cancer
- Cardiovascular Disease
- Genomic Instability
- Mutational Signatures
- Gene Expression
- Precision Medicine
- Immunity
- Cancer Immunotherapy
- PD-1 and PD-L1
- Insulin Resistance
- SARS-CoV-2
- Cardiovascular Risk
- Glycosylation
- Lymphoma
- Tumor Targeting
- Fc Receptors
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this city's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology35▲ 2.0×83 topics
- Inflammation23▲ 2.6×60 topics
- Immunotherapy20▲ 6.4×16 topics
- Targeted Therapy17▲ 18×4 topics
- Cell-Free DNA16▲ 38×2 topics
- Metabolic Syndrome16▲ 4.4×18 topics
- Machine Learning15◆ 1.08×24 topics
- Tumor Microenvironment12▲ 6.5×7 topics
- Cancer12▲ 2.1×32 topics
- Clinical Trials12▲ 4.2×11 topics
- Cardiovascular Disease12▲ 2.5×23 topics
- Oxidative Stress12▲ 1.67×37 topics
- Genomic Instability12▲ 24×2 topics
- Cancer Genomics11▲ 36×1 topic
- Mutational Signatures11▲ 36×1 topic
- Biomarkers11▲ 3.8×15 topics
- Gene Expression11▲ 4.1×11 topics
- Chemotherapy10▲ 3.4×18 topics
- Precision Medicine10▲ 4.9×7 topics
- Monoclonal Antibodies10▲ 24×3 topics
- Immunity9▲ 4.9×8 topics
- Tumor Regression8▲ 18×2 topics
- Cancer Immunotherapy8▲ 12×3 topics
- Immune Checkpoint Blockade8▲ 17×1 topic
- PD-1 and PD-L18▲ 17×1 topic
- Data Analysis8▲ 6.8×4 topics
- Insulin Resistance8▲ 4.0×8 topics
- Prognostic Factors8▲ 4.0×8 topics
- SARS-CoV-27▲ 5.0×6 topics
- Genetic Testing7▲ 14×3 topics
- Cardiovascular Risk7▲ 5.1×8 topics
- Gene Therapy7▲ 8.3×5 topics
- Glycosylation7▲ 14×3 topics
- Mass Spectrometry7▲ 10×4 topics
- Lymphoma6▲ 9.3×3 topics
- Prenatal Diagnosis6▲ 9.4×5 topics
- Tumor Targeting6▲ 7.8×3 topics
- Antibody Engineering5▲ 22×1 topic
- Fc Receptors5▲ 22×1 topic
- Therapeutic Antibodies5▲ 17×2 topics
What research is done in Burlington?
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 11 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 8 works
- 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 5 works
- 4 CAR-T cell therapy research Oncology 5 works
- 5 Prenatal Screening and Diagnostics Pediatrics, Perinatology and Child Health 5 works
- 6 Animal testing and alternatives Small Animals 4 works
- 7 Biosimilars and Bioanalytical Methods Immunology 4 works
- 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
- 9 Immunodeficiency and Autoimmune Disorders Immunology 4 works
- 10 Cancer Research and Treatments Biotechnology 4 works
Research output over time
The same series as a ribbon — one cell per year, darker for more.